Search
Products
Community
Markets
News
Brokers
More
IN
Get started
AUROBINDO PHARMA LTD
Long
Updated
Nov 16, 2017
Auropharma-Down Wedge-Can it stop the fall of false breakout@809
1
6
Grab this chart
Grab this chart
Nov 15, 2017
False breakout above 800 - got extended down beyond 725 which was magical level to hold auro for couple of times finally piercing the level.
809 to 689 - Extended downside & close to very important level of 665.
False Breakout -Trying to tell you something@800
Next Trading Opportunity
Safe Traders can look for an opportunity once it starts moving above 710
Risky Traders can look to jump at 695-700 zone once you get confirmation on your end.
Nov 16, 2017
Trade active
10:38 Hrs 16th Nov2017
Last price@704
Gap Up - Risky Traders are in the trade.
Nov 16, 2017
Trade active
12:40 Hrs 16th Nov2017
Last Price
711
Started - Can it be Awesome Move
Nov 16, 2017
Note
12:45 Hrs 16th Nov2017
Last Price@709.50
We will book partial profits & try to enter if we get a chance close to 700-702 zone or above 711-712 - if it fires next
Nov 16, 2017
Trade active
13:01 Hrs 16th Nov2017
Last price@708
707-707.50 is minor support -if holds then also we can have upside push or below 707 -we shall come back later.
Above 711-712 - is obviously upside.
Nov 16, 2017
Trade active
13:31 Hrs 16th Nov2017
Last Price@710
Pushes upside from minor support zone 707 -707.50 as updated last.
Nov 16, 2017
Trade closed manually
14:07 Hrs 16th Nov2017
Last Price@710
Closing The Update - Take Care. Thanks
WaveTalks
Follow
Best Regards,
Abhishek H. Singh
Growth Director - TradingView India
YouTube Channel
youtube.com/channel/UCYcnYveYBNLD-Qp54hvZogw
Twitter Handle
twitter.com/TalksWave
Telegram Handle
(Deleted)
Also on:
Chart Patterns
Trend Analysis
Wedge
WaveTalks
Follow
Best Regards,
Abhishek H. Singh
Growth Director - TradingView India
YouTube Channel
youtube.com/channel/UCYcnYveYBNLD-Qp54hvZogw
Twitter Handle
twitter.com/TalksWave
Telegram Handle
(Deleted)
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.